UBS Lux Equity Fund Biotech USD vs Nordnet Indexfond Europa

UBS Lux Equity Fund Biotech USD vs Nordnet Indexfond Europa

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Nordnet Indexfond Europa

  • Security

    Nordnet Indexfond Europa ESG

  • Fee

    0.20%

  • ISIN

    IE00BMTD2L82

  • Holdings

    16

  • Number of owning funds

    3

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with Nordnet Indexfond Europa, we have 25 holdings where AstraZeneca is the largest holding (3.82), followed by Novo Nordisk (3.67) and HSBC Holdings (3.41).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Nordnet Indexfond Europa.

UBS Lux Equity Fund Biotech USD Nordnet Indexfond Europa
1. Regeneron Pharmaceuticals Inc
10.04 %
1. AstraZeneca
Sweden UK
3.82 %
2. Vertex Pharmaceuticals Inc
9.35 %
2. Novo Nordisk ADR
Denmark
3.67 %
3. Moderna Inc
9.21 %
3. HSBC Holdings PLC
UK
3.41 %
4. Alnylam Pharmaceuticals Inc
6.96 %
4. Unilever Plc
UK
2.71 %
5. AbbVie Inc
USA
5.53 %
5. TotalEnergies SE
France
2.16 %
6. Gilead Sciences Inc
USA
4.66 %
6. Iberdrola SA
Spain
1.81 %
7. Amgen Inc
4.3 %
7. RELX ADR
UK
1.74 %
8. BioNTech SE
4.13 %
8. Spotify Technology SA
Sweden
1.62 %
9. Karuna Therapeutics Inc
3.75 %
9. Muenchener Rueckversicherungs-Gesellschaft AG
Germany
1.57 %
10. Royalty Pharma Plc
3.37 %
10. Hermes International SCA
France
1.48 %
- 11. AXA SA
France
1.44 %
- 12. ABB Ltd
Sweden Switzerland
1.43 %
- 13. Intesa Sanpaolo SpA
Italy
1.38 %
- 14. National Grid Plc
UK
1.22 %
- 15. Enel SpA
1.21 %
- 16. Prosus NV
Netherlands
1.09 %

The list of fund holdings was last updated on June 5, 2025.